Armotraz

✅ Reduces breast cancer risk
✅ Inhibits estrogen production
✅ Treats infertility issues
✅ Manages postmenopausal symptoms
✅ Prevents cancer recurrence

This product is currently out of stock and unavailable.

Armotraz Tablet is prescribed either as monotherapy or in combination with other treatments like surgery or radiation therapy for managing early-stage breast cancer in postmenopausal women. It also serves as first-line therapy for advanced breast cancer that has metastasized within breast tissue or to distant sites.

As an aromatase inhibitor, Armotraz Tablet reduces estrogen production in the body. The medication can be administered with or without meals, though maintaining consistent daily dosing timing optimizes therapeutic outcomes. Strict adherence to your physician’s prescribed regimen is essential. Dosage frequency and strength are determined by your specific condition. The tablets should be swallowed intact with water. Continue treatment for the full prescribed duration.

Common adverse effects may include hot flashes, nausea, skin eruptions, arthralgia, bone density loss, and fatigue. Consult your healthcare provider if these symptoms become bothersome or severe, as management strategies may be available.

Prior to initiating therapy, disclose if you’re premenopausal with active menstruation or have hepatic/renal impairment. Provide a complete list of current medications as certain drugs may diminish efficacy or alter pharmacokinetics. Pregnancy and lactation status should be communicated. Your physician may monitor vitamin D levels and bone mineral density through periodic testing.

THERAPEUTIC INDICATIONS

  • Management of breast carcinoma

CLINICAL BENEFITS

In Breast Cancer Management

Armotraz Tablet alleviates clinical manifestations of breast cancer including palpable masses, nipple discharge, and breast tissue alterations. Its mechanism involves modulation of hormone production critical for carcinogenesis and metastasis. The agent may exert direct antitumor effects or interact with hormonal pathways to inhibit neoplastic proliferation.

ADVERSE EFFECTS PROFILE

Most adverse reactions are transient and resolve with continued therapy as physiological adaptation occurs. Medical consultation is recommended for persistent or concerning symptoms.

Frequently Reported Reactions

  • Vasomotor symptoms (hot flashes)
  • Gastrointestinal discomfort
  • Decreased bone mineralization
  • Cutaneous eruptions
  • Asthenia

ADMINISTRATION GUIDELINES

Administer exactly as prescribed regarding dosage and treatment duration. The tablet must be swallowed whole without chewing, crushing, or dividing. While food intake doesn’t affect absorption, maintaining regular dosing schedules enhances treatment consistency.

PHARMACOLOGICAL ACTION

Armotraz Tablet exerts its therapeutic effect through aromatase enzyme inhibition, thereby suppressing endogenous estrogen synthesis. This endocrine modulation inhibits proliferation of hormone receptor-positive breast cancer cells dependent on estrogen signaling pathways.

Important Notice:

This information is provided for educational purposes after rigorous medical review. However, it does not substitute professional medical advice, diagnosis, or treatment. The content may not encompass all potential adverse effects, contraindications, or drug interactions. Always consult your healthcare provider regarding any medical condition or therapeutic regimen. This material aims to complement, not replace, the crucial relationship between patients and their physicians.

Strength

1 mg

Quantity

30 Tablet/s, 60 Tablet/s, 90 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Cipla Inc

Treatment

Breast cancer

Generic Brand

Exemestane

Reviews

There are no reviews yet

Add a review
Armotraz Armotraz
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot